Global Ventilator Demand Analysis-COVID-19 Impact (Feb-Dec 2020): Emphasis on Major COVID-19 Impacted Country
- UNI4065919
- 135 Pages
- May 2020
- Healthcare
COVID-19 Cases, Globally
Note: As of 30th April 2020
Around the world, strict lockdowns were imposed as the COVID-19 outbreak took hold. From Australia to Africa, from America to Europe and to Asia, cities were shut down, restricting how often people were allowed to leave their homes and for what reason. India has asked 1.3 billion citizens of the country to stay home. As of April 30, 2020; the total coronavirus cases topped 3.3 million as more than 85,463 people contracted the infection in a single day on April 30th 2020. The death toll worldwide as of 30th April stands at 233,830 and the number of recoveries at 1,039,061. Nearly 80% of the coronavirus cases are from United States and Europe. United States accounts for more than 33.1% while Europe is the most affected continent
Note: As of 30th April 2020
Chinese Centre for Disease Control and Prevention finding reveals that 80.9% of the total coronavirus cases were classified as mild while 13.8% and 4.7% were categorized as severe and critical respectively. A COVID-19 related lung injury is typically classified as an acute respiratory distress syndrome (ARDS). Severely ill COVID-19 patients will need ventilators and so increasing cases, the demand for ventilator is on the rise from across the world.
Ventilator shortages are a vital fact, as the epidemic of COVID-19 continues to deteriorate. Health ministries all over the world face the same dreadful equation. In order to prevent the deaths of tens of thousands, even hundreds of thousands, the manufacturers have already boosted their production to maximum by themselves. Today, they aren’t receiving orders from regular customers like hospitals only but also directly from the governments. For instance: Hamilton Medical, which usually produces about 15,000 of the devices a year, has ramped up production about 40%, because of the COVID-19 outbreak.
Insights Presented in the Report
“Amongst Region, United States is expected to need more of ventilators amid COVID-19”
For better understanding on the ventilator demand trend arises due to COVID-19, detailed analysis was conducted for top 10 most affected regions including United States, Germany, United Kingdom, France, Italy, Spain, Russia, Turkey, Iran, and India. United States currently has the highest number of ventilators available and is expected to need even more than any other country across the world as the region acquires for more than 33% of the global COVID-19 cases alone and the cases are still on rise.
Reasons to buy this report:
• The study includes current and demand forecast of ventilator due to COVID-19 outbreak
• The report present company’s initiative amid COVID-19 to fulfill the shortfall of ventilator demand
• The report covers in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends and opportunities prevailing in the industry
• The study comprehensively covers the ventilator demand and stakeholders approach in limiting its gap
• Deep dive country level analysis of the COVID-19
Customization Options:
Ventilator Demand-COVID-19 Impact report can further be customized as per the clients requirements (interested country). Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.
1.1 Market Definition 13
1.2 Objective of the Study 13
1.3 Limitation 13
1.4 Stakeholders 14
1.5 Currency used in the Report 14
1.6 Scope of the Ventilator Market Study 14
2. RESEARCH METHODOLOGY OR ASSUMPTION 15
2.1 Research Methodology for the Global Ventilator Demand Analysis-COVID-19 Impact 15
2.1.1 Main objective of the Global Ventilator Demand Analysis-COVID-19 Impact 16
3. EXECUTIVE SUMMARY 17
4. MARKET DYNAMICS 21
4.1 Market Introduction 21
4.1.1 Market Trend & Drivers 21
4.1.1.1 Growing Cases of COVID-19 21
4.1.1.2 Rising Number of ICU Beds 22
4.1.1.3 Rising Government Support 24
4.1.1.3.1 Initial Projects Approved 24
4.1.2 Market Challenges 26
4.1.2.1 Aviation Ban 26
4.1.2.2 Complications Associated With the Use of Ventilators 28
4.1.3 Market Opportunities 29
4.1.3.1 3D-Printed Ventilators 29
5. DEMAND AND SUPPLY SIDE ANALYSIS 30
5.1 Demand Side Analysis 30
5.2 Supply Side Analysis 31
5.2.1 Six tasks the supplier should keep a check on 32
5.2.1.1 Map the ventilator supply chain 32
5.2.1.2 Trace better pathways 32
5.2.1.3 Forecast demand 32
5.2.1.4 Recruit more help 32
5.2.1.5 Prepare the operators 32
5.2.1.6 Look for alternatives 32
5.2.2 Private Company and its initiatives for Ventilator production 33
5.2.2.1 Automotive OEM Initiatives 33
5.2.2.2 Electronic OEM Initiatives 34
5.2.2.3 Medical Device Manufacturer Initiatives 35
5.2.2.4 Other OEM Initiatives 36
6. MEDICAL DEVICE VALUE CHAIN 38
6.1 General Overview 38
7. VENTILATOR DEMAND INSIGHTS BY COUNTRY 40
7.1 General Overview 40
7.1.1 US Ventilator Demand-COVID-19 Impact 41
7.1.1.1 US Government’s effort to secure more ventilators 42
7.1.1.2 Facts on COVID-19 Cases Feb-Dec 2020 44
7.1.1.3 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 44
7.1.1.4 UnivDatos Analysis on Ventilator Demand in the US amid COVID-19 45
7.1.2 Germany Ventilator Demand-COVID-19 Impact 45
7.1.2.1 Facts on COVID-19 Cases Feb-Dec 2020 46
7.1.2.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 47
7.1.2.3 UnivDatos Analysis on Ventilator Demand in Germany amid COVID-19 47
7.1.3 UK Ventilator Demand-COVID-19 Impact 47
7.1.3.1 Facts on COVID-19 Cases Feb-Dec 2020 48
7.1.3.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 49
7.1.3.3 UnivDatos Analysis on Ventilator Demand in the UK amid COVID-19 50
7.1.4 Italy Ventilator Demand-COVID-19 Impact 50
7.1.4.1 Facts on COVID-19 Cases Feb-Dec 2020 51
7.1.4.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 51
7.1.4.3 UnivDatos Analysis on Ventilator Demand in Italy amid COVID-19 52
7.1.5 France Ventilator Demand-COVID-19 Impact 52
7.1.5.1 Agile innovation by Private Players 53
7.1.5.2 Facts on COVID-19 Cases Feb-Dec 2020 53
7.1.5.3 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 54
7.1.5.4 UnivDatos Analysis on Ventilator Demand in France amid COVID-19 55
7.1.6 Spain Ventilator Demand-COVID-19 Impact 55
7.1.6.1 Facts on COVID-19 Cases Feb-Dec 2020 56
7.1.6.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 56
7.1.6.3 UnivDatos Analysis on Ventilator Demand in Spain amid COVID-19 57
7.1.7 Turkey Ventilator Demand-COVID-19 Impact 57
7.1.7.1 Facts on COVID-19 Cases Feb-Dec 2020 58
7.1.7.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 59
7.1.7.3 UnivDatos Analysis on Ventilator Demand in Turkey amid COVID-19 60
7.1.8 Iran Ventilator Demand-COVID-19 Impact 60
7.1.8.1 Facts on COVID-19 Cases Feb-Dec 2020 61
7.1.8.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 61
7.1.8.3 UnivDatos Analysis on Ventilator Demand in Iran amid COVID-19 62
7.1.9 Russia Ventilator Demand-COVID-19 Impact 62
7.1.9.1 Facts on COVID-19 Cases Feb-Dec 2020 63
7.1.9.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 64
7.1.9.3 UnivDatos Analysis on Ventilator Demand in Russia amid COVID-19 65
7.1.10 India Ventilator Demand-COVID-19 Impact 65
7.1.10.1 Facts on COVID-19 Cases Feb-Dec 2020 66
7.1.10.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 66
7.1.10.3 UnivDatos Analysis on Ventilator Demand in India amid COVID-19 67
7.1.11 Brazil Ventilator Demand-COVID-19 Impact 67
7.1.11.1 Facts on COVID-19 Cases Feb-Dec 2020 68
7.1.11.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 69
7.1.11.3 UnivDatos Analysis on Ventilator Demand in Brazil amid COVID-19 69
7.1.12 Rest of World Ventilator Demand-COVID-19 Impact 70
7.1.12.1 Facts on COVID-19 Cases Feb-Dec 2020 70
7.1.12.2 Facts on Ventilator availability and Demand amid COVID-19 Feb-Dec 2020 71
7.1.12.3 UnivDatos Analysis on Ventilator Demand in ROW amid COVID-19 72
8. COMPETITIVE SCENARIO 73
8.1 Competitive Landscape 73
8.1.1 Market Share of Key Players in Global Ventilator Market, 2019 73
9. TOP COMPANY PROFILES 74
9.1 Getinge AB 74
9.1.1 Key Facts 74
9.1.2 Business Description 75
9.1.3 Key Product/Services Offerings 76
9.1.4 Growth Strategy 77
9.1.5 SWOT Analysis 78
9.1.6 Key Financials 79
9.1.6.1 Revenue Split 80
9.1.7 Recent developments 80
9.1.7.1 Product Launch 80
9.1.7.2 Partnership 81
9.1.7.3 Business Expansion and Investment 81
9.1.7.4 Merger and Acquisitions 81
9.2 Hamilton Medical 82
9.2.1 Key Facts 82
9.2.2 Business Description 82
9.2.3 Key Product/Services Offerings 82
9.2.4 Growth Strategy 83
9.2.5 SWOT Analysis 83
9.2.6 Recent developments 84
9.2.6.1 Product Launch 84
9.2.6.2 Partnership 84
9.3 Drägerwerk AG 85
9.3.1 Key Facts 85
9.3.2 Business Description 85
9.3.3 Key Product/Services Offerings 86
9.3.4 Growth Strategy 87
9.3.5 SWOT Analysis 87
9.3.6 Key Financials 88
9.3.6.1 Revenue Split 89
9.3.7 Recent developments 89
9.3.7.1 Product Launch 89
9.3.7.2 Partnership 90
9.3.7.3 Business Expansion and Investment 90
9.3.7.4 Merger and Acquisitions 90
9.4 Mindray Medical International Limited 91
9.4.1 Key Facts 91
9.4.2 Business Description 91
9.4.3 Key Product/Services Offerings 92
9.4.4 Growth Strategy 92
9.4.5 SWOT Analysis 93
9.4.6 Recent developments 93
9.4.6.1 Partnership 93
9.5 Medtronic PLC 94
9.5.1 Key Facts 94
9.5.2 Business Description 95
9.5.3 Key Product/Services Offerings 95
9.5.4 Growth Strategy 96
9.5.5 SWOT Analysis 97
9.5.6 Key Financials 98
9.5.6.1 Revenue Split 99
9.5.7 Recent developments 99
9.5.7.1 Product Launch 99
9.5.7.2 Partnership 100
9.5.7.3 Business Expansion and Investment 100
9.5.7.4 Merger and Acquisitions 101
9.6 GE Healthcare 102
9.6.1 Key Facts 102
9.6.2 Business Description 102
9.6.3 Key Product/Services Offerings 103
9.6.4 Growth Strategy 103
9.6.5 SWOT Analysis 104
9.6.6 Key Financials 105
9.6.6.1 Revenue Split 106
9.6.7 Recent developments 106
9.6.7.1 Product Launch 106
9.6.7.2 Partnership 107
9.6.7.3 Business Expansion and Investment 107
9.7 Philips 108
9.7.1 Key Facts 108
9.7.2 Business Description 108
9.7.3 Key Product/Services Offerings 109
9.7.4 Growth Strategy 109
9.7.5 SWOT Analysis 110
9.7.6 Key Financials 111
9.7.6.1 Revenue Split 112
9.7.7 Recent developments 112
9.7.7.1 Product Launch 112
9.7.7.2 Partnership 113
9.7.7.3 Merger and Acquisitions 113
9.8 Fisher & Paykel Healthcare 114
9.8.1 Key Facts 114
9.8.2 Business Description 114
9.8.3 Key Product/Services Offerings 114
9.8.4 Growth Strategy 115
9.8.5 SWOT Analysis 116
9.8.6 Key Financials 117
9.8.6.1 Revenue Split 118
9.8.7 Recent developments 118
9.8.7.1 Product Launch 118
9.8.7.2 Partnership 119
9.9 VYAIRE Medical Inc. 120
9.9.1 Key Facts 120
9.9.2 Business Description 120
9.9.3 Key Product/Services Offerings 120
9.9.4 Growth Strategy 122
9.9.5 SWOT Analysis 122
9.9.6 Recent developments 123
9.9.6.1 Product Launch 123
9.9.6.2 Partnership 123
9.9.6.3 Business Expansion and Investment 123
9.10 ResMed 124
9.10.1 Key Facts 124
9.10.2 Business Description 124
9.10.3 Growth Strategy 126
9.10.4 SWOT Analysis 126
9.10.5 Key Financials 127
9.10.5.1 Revenue Split 128
9.10.6 Recent developments 128
9.10.6.1 Product Launch 128
9.10.6.2 Partnership 129
9.10.6.3 Merger and Acquisitions 129
TABLE 2 List of Electronics OEM and their initiatives for Ventilator production 34
TABLE 3 List of Medical Devices Supplier and their initiatives for Ventilator production 35
TABLE 4 List of Consortium OEM and their initiatives for Ventilator production 36
TABLE 5 List of Other OEM and their initiatives for Ventilator production 36
TABLE 6 US Facts on COVID-19 Cases Feb-Jun 2020 (in units) 44
TABLE 7 US Ventilator Availability and Demand Amid Covid-19 44
TABLE 8 Germany Facts on COVID-19 Cases Feb-Jun 2020 (in units) 46
TABLE 9 Germany Ventilator Availability and Demand Amid Covid-19 47
TABLE 10 UK Facts on COVID-19 Cases Feb-Jun 2020 (in units) 48
TABLE 11 UK Ventilator Availability and Demand Amid Covid-19 49
TABLE 12 Italy Facts on COVID-19 Cases Feb-Jun 2020 (in units) 51
TABLE 13 Italy Ventilator Availability and Demand Amid Covid-19 51
TABLE 14 France Facts on COVID-19 Cases Feb-Jun 2020 (in units) 53
TABLE 15 France Ventilator Availability and Demand Amid Covid-19 54
TABLE 16 Spain Facts on COVID-19 Cases Feb-Jun 2020 (in units) 56
TABLE 17 Spain Ventilator Availability and Demand Amid Covid-19 56
TABLE 18 Turkey Facts on COVID-19 Cases Feb-Jun 2020 (in units) 58
TABLE 19 Turkey Ventilator Availability and Demand Amid Covid-19 59
TABLE 20 Iran Facts on COVID-19 Cases Feb-Jun 2020 (in units) 61
TABLE 21 Iran Ventilator Availability and Demand Amid Covid-19 61
TABLE 22 Russia Facts on COVID-19 Cases Feb-Jun 2020 (in units) 63
TABLE 23 Russia Ventilator Availability and Demand Amid Covid-19 64
TABLE 24 India Facts on COVID-19 Cases Feb-Jun 2020 (in units) 66
TABLE 25 India Ventilator Availability and Demand Amid Covid-19 66
TABLE 26 Brazil Facts on COVID-19 Cases Feb-Jun 2020 (in units) 68
TABLE 27 Brazil Ventilator Availability and Demand Amid Covid-19 69
TABLE 28 ROW Facts on COVID-19 Cases Feb-Jun 2020 (in units) 70
TABLE 29 ROW Ventilator Availability and Demand Amid Covid-19 71
TABLE 30 Getinge AB Key Facts 74
TABLE 31 Getinge AB Ownership Structure 74
TABLE 32 Products segmentation of Getinge AB 76
TABLE 33 Getinge AB Growth Strategy 77
TABLE 34 Getinge AB Product Launch 80
TABLE 35 Getinge AB Partnership 81
TABLE 36 Getinge AB Business Expansion and Investment 81
TABLE 37 Getinge AB Merger and Acquisitions 81
TABLE 38 Hamilton Medical Key Facts 82
TABLE 39 Products segmentation of Hamilton Medical 82
TABLE 40 Hamilton Medical Growth Strategy 83
TABLE 41 Hamilton Medical Product Launch 84
TABLE 42 Hamilton Medical Partnership 84
TABLE 43 Drägerwerk AG, Key Facts 85
TABLE 44 Drägerwerk AG Ownership Structure 85
TABLE 45 Products segmentation of Drägerwerk AG 86
TABLE 46 Drägerwerk AG Growth Strategy 87
TABLE 47 Drägerwerk AG Product Launch 89
TABLE 48 Drägerwerk AG Partnership 90
TABLE 49 Drägerwerk AG Business Expansion and Investment 90
TABLE 50 Drägerwerk AG Merger and Acquisitions 90
TABLE 51 Mindray Medical International Limited, Key Facts 91
TABLE 52 Products segmentation of Mindray Medical International Limited 92
TABLE 53 Mindray Medical International Limited Growth Strategy 92
TABLE 54 Mindray Medical International Limited Partnership 93
TABLE 55 Medtronic PLC, Key Facts 94
TABLE 56 Medtronic PLC, Ownership Structure 94
TABLE 57 Products segmentation of Medtronic PLC 95
TABLE 58 Medtronic PLC Growth Strategy 96
TABLE 59 Medtronic PLC, Product Launch 99
TABLE 60 Medtronic PLC, Partnership 100
TABLE 61 Medtronic PLC, Business Expansion and Investment 100
TABLE 62 Medtronic PLC, Merger and Acquisitions 101
TABLE 63 GE Healthcare, Key Facts 102
TABLE 64 Products segmentation of GE Healthcare 103
TABLE 65 GE Healthcare, Growth Strategy 103
TABLE 66 GE Healthcare, Product Launch 106
TABLE 67 GE Healthcare, Partnership 107
TABLE 68 GE Healthcare, Business Expansion and Investment 107
TABLE 69 Philips, Key Facts 108
TABLE 70 Philips, Ownership Structure 108
TABLE 71 Products segmentation of Philips 109
TABLE 72 Philips, Growth Strategy 109
TABLE 73 Philips, Product Launch 112
TABLE 74 Philips, Partnership 113
TABLE 75 Philips, Merger and Acquisitions 113
TABLE 76 Fisher & Paykel Healthcare, Key Facts 114
TABLE 77 Products segmentation of Fisher & Paykel Healthcare 114
TABLE 78 Fisher & Paykel Healthcare, Growth Strategy 115
TABLE 79 Fisher & Paykel Healthcare, Product Launch 118
TABLE 80 Fisher & Paykel Healthcare, Partnership 119
TABLE 81 VYAIRE Medical Inc., Key Facts 120
TABLE 82 Products segmentation of VYAIRE Medical Inc. 120
TABLE 83 VYAIRE Medical Inc., Growth Strategy 122
TABLE 84 VYAIRE Medical Inc., Product Launch 123
TABLE 85 VYAIRE Medical Inc., Partnership 123
TABLE 86 VYAIRE Medical Inc., Business Expansion and Investment 123
TABLE 87 ResMed, Key Facts 124
TABLE 88 ResMed Ownership Structure 124
TABLE 89 Products segmentation of ResMed 125
TABLE 90 ResMed, Growth Strategy 126
TABLE 91 ResMed, Product Launch 128
TABLE 92 ResMed, Partnership 129
TABLE 93 ResMed, Merger and Acquisitions 129
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
